Current treatment of recurrent nasopharngeal carcinoma
10.3760/cma.j.cn113030-20200220-00065
- VernacularTitle:复发鼻咽癌治疗现状
- Author:
Meilin HE
1
;
Junlin YI
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科 100021
- Keywords:
Neoplasm recurrent, nasopharynx/recourse radiotherapy;
Neoplasm recurrent, nasopharynx/recourse surgery;
Neoplasm recurrent, nasopharynx/targeted therap
- From:
Chinese Journal of Radiation Oncology
2021;30(11):1202-1208
- CountryChina
- Language:Chinese
-
Abstract:
On the basis of intensity-modulated radiotherapy (IMRT)-based comprehensive treatment, the 5-year overall survival rate of initially-treated nasopharngeal carcinoma patients without recurrence and metastasis has reached 80%, local regional control rate has exceeded 90%, whereas approximately 10%-15% of patients will suffer from local and/or nodal recurrence after initial treatment. The factors affecting the decision-making of re-treatment mainly include the causes of local and/or nodal recurrence of nasopharngeal carcinoma after initial treatment, selection of re-treatment, side effects and efficacy after re-treatment. This article summarizes the recent progress on these issues above.
